科研之友
微信
新浪微博
Facebook
分享链接
摘要
Aim: The study aims to assess the risk of developing hyponatraemia when large-volume bolus fluid rehydration therapy is administered. %26lt;br%26gt;Methods: We conducted a prospective randomised study in a tertiary-care centre emergency department. Participants included children with gastroenteritis and dehydration requiring intravenous rehydration. They were randomised to receive 60 mL/kg (large) or 20 mL/kg (standard) 0.9% saline bolus followed by maintenance 0.9% saline for 3 h. Biochemical tests were performed at baseline and 4 h. The primary outcome measure was the development of hyponatraemia at 4 h. Secondary outcome measures were (i) change in sodium relative to baseline value; (ii) magnitude of decrease among those who experienced a decrease; (iii) risk of hypernatraemia; (iv) correlations between urine parameters and hyponatraemia; and (v) fluid overload. %26lt;br%26gt;Results: Eighty-four of 224 (38%) participants were hyponatraemic at baseline. At 4 h, 22% (48/217) had a dysnatraemia, and similar numbers of children were hyponatraemic in both groups: large (23% (26/112)) versus standard (21% (22/105)) (P = 0.69). Among initially hyponatraemic children, 63% (30/48) who received large-volume rehydration and 44% (15/34) of those administered standard rehydration were isonatraemic at 4 h (P = 0.10). Overall, children who received 60 mL/kg experienced a larger mean increase (1.6 +/- 2.4 mEq/L vs. 0.9 +/- 2.2 mEq/L; P = 0.04) and were less likely to experience a sodium decrease of %26gt;= 2 mEq/L (8/112 vs. 17/105; P = 0.04) than those administered 20 mL/kg. %26lt;br%26gt;Conclusions: Large-volume bolus rehydration therapy with 0.9% saline is safe. It does not promote the development of hyponatraemia over the short term, but hastens the resolution of baseline hyponatraemia.
- 出版日期2013-3
